Convalife (Shanghai) Co., Ltd.
Registry sponsor category
Industry
- Other names
- Convalife (Shanghai) Co., Ltd.
- Company name
- Convalife (Shanghai) Co., Ltd.
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (9)
- A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
- Clinical Study of CVL006 Combination With 9MW2821
- Clinical Study of CVL006 Injection in Advanced Solid Tumors
- CVL006 Combination Therapy in Advanced Solid Tumors
- CVL237 Tablets for APDS/PASLI
- CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency
- Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR Mutations
- Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations
- Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases